Group One Trading
EGRX

Group One Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Group One Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,100
Closed -$4.1K – 8185
2024
Q3 		$4.1K Buy
1,100
+100
+10% +$477 ﹤0.01% 5951
2024
Q2 		$5.6K Buy
+1,000
New +$4.36K ﹤0.01% 5899
2024
Q1 		– Sell
-5,400
Closed -$28.2K – 8153
2023
Q4 		$28.2K Buy
+5,400
New +$53.3K ﹤0.01% 5490
2020
Q1 		– Sell
-32,000
Closed -$1.92M – 5859
2019
Q4 		$1.92M Buy
32,000
+19,000
+146% +$1.13M 0.01% 1312
2019
Q3 		$735K Sell
13,000
-12,800
-50% -$720K 0.01% 2012
2019
Q2 		$1.44M Buy
25,800
+22,800
+760% +$1.19M 0.01% 1343
2019
Q1 		$151K Sell
3,000
-6,000
-67% -$267K ﹤0.01% 2893
2018
Q4 		$363K Sell
9,000
-25,700
-74% -$1.32M ﹤0.01% 2217
2018
Q3 		$2.41M Buy
34,700
+10,000
+40% +$758K 0.02% 1021
2018
Q2 		$1.87M Buy
24,700
+600
+2% +$37.7K 0.02% 1183
2018
Q1 		$1.27M Buy
24,100
+18,400
+323% +$1.07M 0.01% 1328
2017
Q4 		$304K Sell
5,700
-22,600
-80% -$1.26M ﹤0.01% 2635
2017
Q3 		$1.69M Sell
28,300
-27,000
-49% -$1.63M 0.02% 1172
2017
Q2 		$4.36M Buy
55,300
+44,100
+394% +$3.61M 0.05% 523
2017
Q1 		$929K Buy
11,200
+11,100
+11,100% +$825K 0.01% 1381
2016
Q4 		$8K Sell
100
-100
-50% -$7.26K ﹤0.01% 4013
2016
Q3 		$14K Sell
200
-18,500
-99% -$1.02M ﹤0.01% 3939
2016
Q2 		$725K Buy
18,700
+700
+4% +$29.1K 0.01% 1454
2016
Q1 		$729K Buy
18,000
+13,000
+260% +$825K 0.01% 1412
2015
Q4 		$443K Sell
5,000
-700
-12% -$55.3K 0.01% 1915
2015
Q3 		$422K Buy
5,700
+5,600
+5,600% +$466K 0.01% 1913
2015
Q2 		$8K Buy
+100
New +$6.51K ﹤0.01% 4374

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Group One Trading's EGRX Position: Q4 2024 in Review

Group One Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 785 shares — an estimated $2.93K sold.

Group One Trading first reported a position in EGRX in Q2 2015 and held it in 9 quarters. The position peaked at $653K in Q4 2018. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Group One Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 785 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $2.93K.
  • Group One Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
  • Group One Trading's Eagle Pharmaceuticals, Inc. position peaked at $653K in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.